PharmAthene (AMEX: PIP) announced that its recombinant Protective Antigen (rPA) was one of the vaccines reported by Immunovaccine, Inc., to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE